Physician profile
Ben Leonard
NPI 1306191218
$74,564.41
in general payments reported to CMS, 2019-2025
13 companies · $12K in 2025
The $12K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,600 · 2020: $19.40 · 2021: $595 · 2022: $18K · 2023: $25K · 2024: $17K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $29K · Travel and Lodging: $19K · Food and Beverage: $3,986 · Consulting Fee: $2,640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $28,790.00 |
| Travel and Lodging | $19,105.55 |
| Food and Beverage | $3,986.20 |
| Consulting Fee | $2,640.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $72,596.32 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Cvi Contact Lens |
| Bausch & Lomb Americas INC. | $505.35 | 2022-2025 | Infuse, Xiidra, Miebo |
| Alcon Vision LLC | $476.61 | 2019-2025 | Clareon, Total30 |
| Genentech USA, INC. | $146.97 | 2024 | Vabysmo |
| Apellis Pharmaceuticals, INC. | $144.90 | 2023 | Syfovre |
| Shire North American Group INC | $139.66 | 2019 | |
| Harrow Eye, LLC | $122.77 | 2024 | Vevye |
| Sun Pharmaceutical Industries INC. | $114.66 | 2022 | |
| Aerie Pharmaceuticals, INC. | $94.50 | 2021 | |
| Sight Sciences, INC. | $94.13 | 2023 | Omni Surgical System |
| Oyster Point Pharma, INC. | $74.34 | 2022 | |
| Abbvie INC. | $34.80 | 2025 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ben Leonard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.